Comparative study of regional cerebral blood flow values measured by Xe CT and Xe SPECT. Acta Neurol Scand 1996: Suppl. 166: 13-16The regional cerebral blood flow (rBCF) values measured by stable xenonenhanced computed tomography (Xe XT) and by radioactive xenon-1 33 single photon emission computed tomography (Xe SPECT) were compared in 16 patients with cerebral infarct. On the non-lesion side Xe SPECT recorded 10.7% higher rCBF values than Xe CT in the anterior cerebral artery territory, while Xe CT recorded 9.6% higher values than Xe SPECT in the middle cerebral artery territory. These differences were not statistically significant. Although the rCBF values were almost the same, no correlation was found between the two methods in the posterior cerebral artery territory and the basal ganglia. Only hemispheric CBF on the non-lesion side showed the same value and a good correlation between the Xe CT and the Xe SPECT. There was a good correlation in the hemispheric CBF values on the lesion side, too. The difference of rCBF between the non-lesion side and the lesion side was expressed smaller in the Xe SPECT than in the Xe CT. This is in agreement with the previous reports that Xe SPECT overestimates the flow in the low flow areas. The higher rCBF values in the anterior cerebral artery territory measured by the Xe SPECT was ascribed to the artifact from the radioactivities in the inhalation mask and the air passages as reported previously. In conclusion, there is no good correlation between the rCBF values measured by the Xe CT and by the Xe SPECT. Only hemispheric CBF shows a good correlation between the two methods.Stable xenon-enhanced computed tomography (Xe CT) is a method of quantitative measurement of regional cerebral blood flow (rCBF), and it is now used as one of the routine examinations in neurological and neurosurgical patients. Two-dimensional quantitative measurement of rCBF using radioactive tracer, xenon-133 ( 133Xe), has been the standard method sine the 1960s. Three-dimensional measurement by '33Xe single photon emission computed tomography (Xe SPECT) was developed for clinical use around 1980 (10, 14), and clinical application of the Xe CT was also started around that time (2, 4, 12). However, comparative study between the Xe CT and the Xe SPECT has been few. We compared the rCBF values measured by the Xe CT and those measured by the Xe
Background: Intracranial hemorrhage after endovascular revascularization for acute ischemic stroke is associated with a poor outcome. Case Presentation: An 86-year-old man developed sudden left hemiparesis. He had a baseline National Institutes of Health Stroke Scale (NIHSS) score of at least 16 and showed no improvement with intravenous administration of tissue plasminogen activator (tPA). Cerebral angiography was performed with conscious sedation, which confirmed an occlusion of the superior division of the right middle cerebral artery (MCA). Microcatheter was used to penetrate the MCA during manipulation of the occluded vessel. We performed transarterial embolization with n-butyl 2-cyanoacrylate (NBCA) to treat intraprocedural arterial perforation during acute revascularization therapy. Hemostasis along with patency of parent artery was achieved. Postoperative computed tomography (CT) confirmed no hemorrhagic lesion. Conclusion: We concluded that embolization using NBCA might be acceptable to be one of the effective hemostatic agents for this purpose.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.